The CAP value-based LSM diagnostic flowchart provides a similar accuracy rate regarding patients with no significant fibrosis or a correct diagnosis of severe liver fibrosis/cirrhosis and a lower rate of misdiagnosis than the ALT-based algorithm. This evidence concerns the gene GPT and Hepatic fibrosis.